KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Non-Current Deferred Tax Liability (2018 - 2022)

Historic Non-Current Deferred Tax Liability for Eli Lilly (LLY) over the last 11 years, with Q4 2022 value amounting to $4.6 billion.

  • Eli Lilly's Non-Current Deferred Tax Liability fell 897.69% to $4.6 billion in Q4 2022 from the same period last year, while for Dec 2022 it was $4.6 billion, marking a year-over-year decrease of 897.69%. This contributed to the annual value of $4.6 billion for FY2022, which is 897.69% down from last year.
  • Latest data reveals that Eli Lilly reported Non-Current Deferred Tax Liability of $4.6 billion as of Q4 2022, which was down 897.69% from $171.9 million recorded in Q3 2022.
  • Over the past 5 years, Eli Lilly's Non-Current Deferred Tax Liability peaked at $5.1 billion during Q4 2020, and registered a low of $171.9 million during Q3 2022.
  • Over the past 5 years, Eli Lilly's median Non-Current Deferred Tax Liability value was $2.2 billion (recorded in 2021), while the average stood at $2.6 billion.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first skyrocketed by 5161.16% in 2019, then plummeted by 8947.01% in 2022.
  • Eli Lilly's Non-Current Deferred Tax Liability (Quarter) stood at $3.0 billion in 2018, then soared by 51.61% to $4.6 billion in 2019, then grew by 10.13% to $5.1 billion in 2020, then decreased by 0.8% to $5.0 billion in 2021, then fell by 8.98% to $4.6 billion in 2022.
  • Its Non-Current Deferred Tax Liability was $4.6 billion in Q4 2022, compared to $171.9 million in Q3 2022 and $862.5 million in Q2 2022.